Trends in Immunology
Volume 24, Issue 1, January 2003, Pages 30-35
Journal home page for Trends in Immunology

Malaria-specific antibody subclasses in immune individuals: a key source of information for vaccine design

https://doi.org/10.1016/S1471-4906(02)00012-1Get rights and content

Abstract

Immunity against the blood stage of Plasmodium falciparum malaria is associated with protective-type antibodies of certain classes and subclasses. Field studies have demonstrated the differential regulation of various IgG subclasses depending on the dynamics of parasite transmission and on the immune status of the individuals tested. The intrinsic properties of each IgG subclass has a crucial role in protection, both because immunoglobulin levels are dependent on their production and clearance from blood and because antibodies are actively used for parasite clearance. In vitro models using B cells obtained from P. falciparum-immune adults have enabled study of the production of various antibody subclasses depending on the individual and on the antigens used. Ex vivo and in vitro observations from immune donors have helped to extend our understanding of the development and regulation of the antibody response and to design more effective vaccine strategies.

Section snippets

Epidemiological support for antibody-mediated protection

Infection by P. falciparum is complex, as shown by the parasite life cycle (Fig. 1). Blood-stage infection, which accounts for the majority of morbidity and mortality, generates a protective response in most individuals exposed repeatedly to the parasite. The acquisition of this type of natural protection is labile and is dependent on the intensity, length and duration of an individual's exposure to the parasite [1]. In general, adults living in areas where transmission is at least mesoendemic

Relationship between IgG subclass properties and mechanisms of antibody-mediated protection

Not only are antibodies markers of infection but they are also effectors of protection in many infectious circumstances. There is good in vivo evidence that antibodies can mediate protection against the blood stage of P. falciparum [14]. Protective IgG antibodies belong to a restricted panel of subclasses, specifically IgG1 and IgG3, whereas IgG4 antibodies are considered nonprotective 15, 16, 17, 18. IgE antibodies have been associated with pathology [19] and no specific function has been

Balances in isotype production and use of antibodies in malaria

To develop better models to explain anti-malarial antibody responses, it is proposed that antibody levels detectable in the plasma or serum of P. falciparum-immune individuals result from a balance between production and use of parasite-specific antibodies. In naturally immune adults, anti-MSP119 IgG1 and IgG3 antibodies appeared to evolve with the seasons, in a manner strongly dependent on the parasite burden in the villages under study, and it was shown that specific IgG1 versus IgG3

In vitro selection of IgG subclasses against malaria antigens

In parallel, several groups 47, 48, 49 have carried out studies in B-cell culture systems using B cells obtained from the blood of individual immune donors. These B cells could differentiate in vitro to produce antibodies of diverse classes/subclasses on in vitro (re)-stimulation either with crude extracts (multiple antigens) of P. falciparum or defined, purified antigens. Sensitized B cells [47] from almost every P. falciparum-immune donor produced all four isotypes of antibodies in vitro when

From the field and towards a vaccine

Blood-stage P. falciparum malaria is a unique example of an infection in which individuals exposed repeatedly to the pathogen acquire immunity and demonstrate definite evidence of cellular and humoral effectors. It is tempting to speculate that, in this infection more than in most, a first ‘wave’ of antibody responses with multiple classes/subclasses is followed by the sustained boosting of the immune system with parasite antigens towards a second ‘wave’ of antibody responses with one or two

Acknowledgements

We are grateful to present and former colleagues and collaborators at the Institut Pasteur in Paris, Dakar (Senegal) and Cayenne (French Guiana) for their respective contribution to the malaria studies. We also acknowledge present and former colleagues at the IRD (ex-ORSTOM) in Dakar, at the departments of Immunology and Parasitology at the University Medical School, University Cheikh Anta Diop in Dakar, and to the villagers of Dielmo and Ndiop (Senegal). This work has received constant support

References (53)

  • F. AlYaman

    Reduced risk of clinical malaria in children infected with multiple clones of Plasmodium falciparum in a highly endemic area. A prospective community study

    Trans. R. Soc. Trop. Med. Hyg.

    (1997)
  • O. Kashala

    Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide SPf66 combined with the immunological adjuvant QS-21

    Vaccine

    (2002)
  • B. Greenwood

    What can the residents of malaria endemic countries do to protect themselves?

    Parassitologia

    (1999)
  • C. Rogier

    Plasmodium falciparum clinical malaria: lessons from longitudinal studies in Senegal

    Parassitologia

    (1999)
  • A.J. Luty

    Interferon-γ responses are associated with resistance with Plasmodium falciparum in young African children

    J. Infect. Dis.

    (1999)
  • H. Bouharoun-Tayoun

    Mechanisms underlying the monocyte-mediated antibody killing of Plasmodium falciparum asexual blood stages

    J. Exp. Med.

    (1995)
  • L.J. Carvalho

    Malaria vaccine: candidate antigens, mechanisms, constraints and prospects

    Scand. J. Immunol.

    (2002)
  • A. Bolad et al.

    Antigenic diversity of Plasmodium falciparum and antibody-mediated parasite neutralization

    Scand. J. Immunol.

    (2000)
  • P. Druihle

    A primary malarial infection is composed of a very wide range of genitically diverse but related mechanisms

    J. Clin. Invest.

    (1998)
  • G. Aribot

    Pattern of immunoglobulin isotype response to Plasmodium falciparum blood-stage antigens in individuals living in a holoendemic area of Senegal (Dielmo, West-Africa)

    Am. J. Trop. Med. Hyg.

    (1996)
  • P. Druilhe

    In vivo veritas: lessons from immunoglobulin transfer experiments in malaria patients

    Ann. Trop. Med. Parasitol.

    (1997)
  • H. Bouharoun-Tayoun et al.

    Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity

    Infect. Immun.

    (1992)
  • C. Rzepzyk

    Humoral immune responses of Solomon islanders to the merozoite surface antigen 2 of Plasmodium falciparum show pronounced skewing towards antibodies of the immunoglobulin G3 subclass

    Infect. Immun.

    (1997)
  • R.R. Taylor

    IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria

    Am. J. Trop. Med. Hyg.

    (1998)
  • M. Troye-Blomberg

    Immune regulation of protection and pathogenesis in Plasmodium falciparum infection

    Parassitologia

    (1999)
  • O.H. Branch

    A longitudinal investigation of IgG and IgM antibody response to the merozoite surface protein-1 19-kilodalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness parasitaemia and anemia

    Am. J. Trop. Med. Hyg.

    (1998)
  • Cited by (55)

    • Current status and future prospective of vaccine development against Echinococcus granulosus

      2018, Biologicals
      Citation Excerpt :

      For instance, AgB is a secretory Ag with variable gene sequence that acts as a key factor in the parasite immune evasion mechanisms [48]. Further, there exists an evolutionary phenomenon that occurs in these mechanisms [49]. With respect to above presuppositions, it seems that concurrent employment of both E/S and surface Ags that originated from different stages of the parasite life cycle can result in the construction of poly-epitopic multifunctional vaccines [15].

    • Immunogenicity of novel nanoparticle-coated MSP-1 C-terminus malaria DNA vaccine using different routes of administration

      2011, Vaccine
      Citation Excerpt :

      It was clearly shown that mice immunized with the NP-coated DNA plasmid produced high levels of IgG and its subtype antibodies (Fig. 2A–C). A significant difference of IgG subtypes (IgG2a and IgG2b) between NP-coated and naked plasmid DNA group in mice immunized by i.p. and i.v. routes of administration was observed (Fig. 2B and C) and this correlated with protection as previously reported [30,50,51]. It was reported that antibodies are required to reduce parasitaemia and CD4+ T cells are required to achieve complete protection, probably to provide T cell help for antibody production [17].

    • Relationship between immunoglobulin isotype response to Plasmodium falciparum blood stage antigens and parasitological indexes as well as splenomegaly in sympatric ethnic groups living in Mali

      2009, Acta Tropica
      Citation Excerpt :

      Of the IgG subclasses, IgG1 and IgG3 are known as protective ones, whereas IgG2 and IgG4 are believed to be non-protective. However, IgG2 might be involved in protection in individuals carrying a certain Fcγ Receptor (R) polymorphism (Garraud et al., 2003a). IgG4 is thought to inhibit the binding of IgG1 and IgG3, thereby counteracting the parasite neutralizing affects of the later antibodies (Garraud et al., 2003b).

    View all citing articles on Scopus
    View full text